/
Axim Biotechnologies, Inc., a Nevada corporation, is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numer…
The business is unprofitable at the operating level (-6960.98% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 345.3% YoY with margins expanding 45464.6pp.
Negative free cash flow of -$1M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$93K
▲ +345.3% YoY
Net Income (TTM)
-$4M
▼ -29.1% YoY
Op. Margin
-2497.01%
▲ +45464.6pp YoY
ROIC
-84.28%
▲ +185.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$759K
▲ +49.8% YoY
Op. Cash Flow (TTM)
-$759K
▲ +49.6% YoY
Net Debt
$6M
Cash & Equiv.
$6K
5Y CAGR: -27.4%
Continue Research